Lead Product(s) : Adrecizumab
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
AdrenoMed Receives FDA Fast Track Designation for Enibarcimab in Septic Shock Treatment
Details : HAM8101 (enibarcimab) is an adrenomedullin receptor binder, intravenously administered, antibody, which is currently being evaluated for the treatment of septic shock.
Product Name : HAM8101
Product Type : Antibody
Upfront Cash : Inapplicable
October 04, 2024
Lead Product(s) : Adrecizumab
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Adrecizumab
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : EMA supports Adrenomed’s strategy to continue development of Adrecizumab based on the completed Phase II trial AdrenOSS-2, which demonstrated favorable safety and tolerability and a positive survival trend.
Product Name : HAM8101
Product Type : Antibody
Upfront Cash : Inapplicable
February 12, 2021
Lead Product(s) : Adrecizumab
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Adrecizumab
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock
Details : The study achieved its primary endpoint: Adrecizumab demonstrated a favorable safety profile and was well tolerated.
Product Name : HAM8101
Product Type : Antibody
Upfront Cash : Inapplicable
February 21, 2020
Lead Product(s) : Adrecizumab
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable